This webinar will focus on progress achieved in G protein-coupled receptor (GPCR) therapeutic antibody-based discovery and development. Xavier Leroy, Chief Technology Officer at Domain Therapeutics, will present how next-generation technologies complement the power of next-generation sequencing.